Forskning ved Københavns Universitet - Københavns Universitet

Forside
Jens Bukh
Jens Bukh

Professor

  • Virology

    Blegdamsvej 3B, Building: 07-13-84

    2200 København N.

    Mobile: +45 23 41 89 69

  1. 2021
  2. Published

    In vitro Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms

    Lassaunière, R., Fonager, J., Rasmussen, M., Frische, A., Polacek, C., Rasmussen, T. B., Lohse, L., Belsham, Graham John, Underwood, Alexander Paul James, Winckelmann, A. A., Bollerup, S., Bukh, Jens, Weis, Nina, Sækmose, S. G., Aagaard, B., Alfaro-Núñez, A., Mølbak, Kåre, Bøtner, Anette Gleitze & Fomsgaard, A., 2021, In: Frontiers in Microbiology. 12, 9 p., 698944.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    In vitro adaptation and characterization of attenuated hypervariable region 1 swap chimeras of hepatitis C virus

    Olesen, Christina Holmboe, Augestad, Elias Honerød, Troise, F., Bukh, Jens & Prentø, Jannick, 2021, In: PLOS Pathogens. 17, July, 29 p., e1009720.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published
  5. Published

    Functional convergence of a germline-encoded neutralizing antibody response in rhesus macaques immunized with HCV envelope glycoproteins

    Chen, F., Tzarum, N., Lin, X., Giang, E., Velázquez-Moctezuma, R., Augestad, Elias Honerød, Nagy, K., He, L., Hernandez, M., Fouch, M. E., Grinyó, A., Chavez, D., Doranz, B. J., Prentø, Jannick, Stanfield, R. L., Lanford, R., Bukh, Jens, Wilson, I. A., Zhu, J. & Law, M., 2021, In: Immunity. 54, 4, p. 781-796.e4

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Global evolutionary analysis of chronic hepatitis C patients revealed significant effect of baseline viral resistance, including novel non-target sites, for DAA-based treatment and retreatment outcome

    Fahnøe, Ulrik, Pedersen, M. S., Sølund, C., Ernst, A., Krarup, H. B., Røge, B. T., Christensen, P. B., Laursen, A. L., Gerstoft, Jan, Thielsen, P., Madsen, Lone Galmstrup, Pedersen, A. G., Schønning, K., Weis, Nina & Bukh, Jens, 2021, In: Journal of Viral Hepatitis. 28, 2, p. 302-316

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Accepted/In press

    HCV genome-wide analysis for development of efficient culture systems and unravelling of antiviral resistance in genotype 4

    Pham, L. V., Pedersen, M. S., Fahnøe, Ulrik, Fernandez-Antunez, C., Humes, D., Schønning, K., Ramirez Almeida, Santseharay & Bukh, Jens, 2021, (Accepted/In press) In: Gut. 20323585.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 in Vitro

    Gammeltoft, Karen Anbro, Zhou, Y., Duarte Hernandez, C. R., Galli, Andrea, Offersgaard, Anna Falden, Costa, R., Pham, L. V., Fahnøe, Ulrik, Feng, S., Scheel, Troels Kasper Høyer, Ramirez Almeida, Santseharay, Bukh, Jens & Gottwein, Judith Margarete, 2021, In: Antimicrobial Agents and Chemotherapy. 65, 9, e02680-20.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Hepatitis C virus envelope protein dynamics and the link to hypervariable region 1

    Augestad, Elias Honerød, Bukh, Jens & Prentø, Jannick, 2021, In: Current Opinion in Virology. 50, p. 69-75 7 p.

    Research output: Contribution to journalReviewResearchpeer-review

  10. Published

    In vitro efficacy of artemisinin-based treatments against SARS-CoV-2

    Zhou, Y., Gilmore, K., Ramirez Almeida, Santseharay, Settels, E., Gammeltoft, Karen Anbro, Pham, L. V., Fahnøe, Ulrik, Feng, S., Offersgaard, Anna Falden, Trimpert, J., Bukh, Jens, Osterrieder, K., Gottwein, Judith Margarete & Seeberger, P. H., 2021, In: Scientific Reports. 11, 14571.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Accepted/In press

    Inferior cure rate in pilot study of 4-week glecaprevir/pibrentasvir treatment with or without ribavirin of chronic hepatitis C

    Madsen, L. W., Christensen, P. B., Fahnøe, Ulrik, Pedersen, M. S., Bukh, Jens & Øvrehus, A., 2021, (Accepted/In press) In: Liver International.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...17 Next

ID: 12437